Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.Published in:NPJ Genomic Medicine, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41525-024-00415-xBy:Venken, Tom;Miller, Ian S.;Arijs, Ingrid;Thomas, Valentina;Barat, Ana;Betge, Johannes;Zhan, Tianzuo;Gaiser, Timo;Ebert, Matthias P.;O'Farrell, Alice C.;Prehn, Jochen;Klinger, Rut;O'Connor, Darran P.;Moulton, Brian;Murphy, Verena;Serna, Garazi;Nuciforo, Paolo G.;McDermott, Ray;Bird, Brian;Leonard, GregoryPublication type:Article